[Form 4] Red Cat Holdings, Inc. Insider Trading Activity
Christopher R. Moe, a director of Red Cat Holdings, Inc. (RCAT), reported multiple open-market sales of common stock in a Form 4 filing. The filing lists four sales executed between 09/08/2025 and 09/12/2025 totaling 50,000 shares sold at reported weighted-average prices of $8.90, $9.77, $10.79, and $10.96. Following the last reported sale on 09/12/2025, the reporting person beneficially owned 63,073 shares. The filing includes footnotes clarifying that the prices for the 9/11 and 9/12 trades are weighted averages across multiple executions and offers to provide detailed breakouts on request. The Form 4 is signed by Christopher R. Moe on 09/15/2025.
- Transparent disclosure of weighted-average sale prices with footnotes and an offer to provide per-trade price breakdowns upon request
- Timely, signed filing by the reporting person, meeting Form 4 reporting formalities
- Insider sold 50,000 shares in four transactions between 09/08/2025 and 09/12/2025
- Reporting shows a reduced beneficial holding of 63,073 shares after the transactions
Insights
TL;DR: Routine disclosure of insider sales; documentation and footnotes improve transparency.
The Form 4 records multiple open-market dispositions by a director totaling 50,000 shares over five days. The filing supplies weighted-average prices and explicit offers to provide per-trade breakdowns, which enhances compliance transparency. The document is signed and timely dated, meeting Section 16 reporting requirements. There is no accompanying information about reasons for the sales or any related transactions (e.g., derivative exercises) in the filing.
TL;DR: Material insider disposals documented; impact depends on context outside this filing.
The investor-relevant facts are clear: 50,000 shares were sold across four transactions from 09/08/2025 to 09/12/2025 with weighted-average prices reported at $8.90, $9.77, $10.79 and $10.96, and ending beneficial ownership of 63,073 shares. The filing contains no earnings, forward guidance, or additional corporate actions to assess market impact, so valuation implications cannot be drawn solely from this Form 4.